CA2098819C - Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene - Google Patents

Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Download PDF

Info

Publication number
CA2098819C
CA2098819C CA002098819A CA2098819A CA2098819C CA 2098819 C CA2098819 C CA 2098819C CA 002098819 A CA002098819 A CA 002098819A CA 2098819 A CA2098819 A CA 2098819A CA 2098819 C CA2098819 C CA 2098819C
Authority
CA
Canada
Prior art keywords
nucleotide
hpv39
dna
papillomavirus
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002098819A
Other languages
English (en)
French (fr)
Other versions
CA2098819A1 (fr
Inventor
Gerard Orth
Christoph Volpers
Rolf E. Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Pasteur filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to CA002375673A priority Critical patent/CA2375673C/fr
Publication of CA2098819A1 publication Critical patent/CA2098819A1/fr
Application granted granted Critical
Publication of CA2098819C publication Critical patent/CA2098819C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/084—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002098819A 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene Expired - Lifetime CA2098819C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002375673A CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.
FR90/16044 1990-12-20
PCT/FR1991/001053 WO1992011369A1 (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002375673A Division CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Publications (2)

Publication Number Publication Date
CA2098819A1 CA2098819A1 (fr) 1992-06-21
CA2098819C true CA2098819C (fr) 2002-06-18

Family

ID=9403488

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002098819A Expired - Lifetime CA2098819C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
CA002375673A Expired - Lifetime CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002375673A Expired - Lifetime CA2375673C (fr) 1990-12-20 1991-12-20 Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene

Country Status (10)

Country Link
US (2) US5656423A (enExample)
EP (1) EP0563255B1 (enExample)
JP (1) JP3859696B2 (enExample)
AT (1) ATE112316T1 (enExample)
CA (2) CA2098819C (enExample)
DE (1) DE69104380T2 (enExample)
DK (1) DK0563255T3 (enExample)
ES (1) ES2062887T3 (enExample)
FR (1) FR2670797A1 (enExample)
WO (1) WO1992011369A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
CA2348413C (en) * 1998-10-26 2008-12-30 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (pap) smears
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
CA2365901A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
JP2004535816A (ja) * 2001-07-20 2004-12-02 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム Ｃｉｎを含むｈｐｖ関連の前癌性増殖および癌性増殖に関する方法および組成物
WO2004002416A2 (en) * 2002-06-26 2004-01-08 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
CA2495449A1 (en) 2002-09-09 2004-03-18 Arbor Vita Corporation Methods of diagnosing cervical cancer
AU2004275865B2 (en) 2003-09-25 2008-09-25 Third Wave Technologies, Inc. Detection of HPV
EP1708745B1 (en) * 2003-12-23 2012-04-18 Arbor Vita Corporation Antibodies for oncogenic strains of hpv and methods of their use
US7354719B2 (en) 2004-12-08 2008-04-08 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
NZ554229A (en) * 2004-12-10 2009-03-31 Genera Biosystems Pty Ltd Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US8859218B2 (en) 2008-06-13 2014-10-14 Oncohealth Corp. In situ detection of early stages and late stages HPV infection
CN101730847B (zh) * 2007-04-05 2015-03-18 分类生物系统有限公司 组合物及检测方法
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2427763A4 (en) 2009-05-07 2013-08-21 Oncohealth Corp IDENTIFICATION OF HIGH GRADE OR CIN2 FOR DETECTION, MONITORING AND DIAGNOSIS, AT EARLY STAGES AND ADVANCED STAGES, OF HUMAN PAPILLOMAVIRUS (HPV) AND HPV ASSOCIATED CANCERS
EP2521914A4 (en) 2010-01-08 2013-07-10 Oncohealth Corp CELL-BASED HPV IMMUNOTESTS HAVE A HIGH PERFORMANCE FOR DIAGNOSIS AND SCANNING OF HPV ASSOCIATED CANCER
EP2576840B1 (en) * 2010-05-25 2018-10-17 QIAGEN Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
FR2641081A1 (enExample) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
DK0563255T3 (da) 1994-10-24
ES2062887T3 (es) 1994-12-16
DE69104380T2 (de) 1995-02-09
CA2375673A1 (fr) 1992-07-09
FR2670797A1 (fr) 1992-06-26
DE69104380D1 (de) 1994-11-03
CA2375673C (fr) 2005-05-17
JP3859696B2 (ja) 2006-12-20
JPH06504672A (ja) 1994-06-02
ATE112316T1 (de) 1994-10-15
WO1992011369A1 (fr) 1992-07-09
EP0563255A1 (fr) 1993-10-06
FR2670797B1 (enExample) 1994-08-19
US5656423A (en) 1997-08-12
EP0563255B1 (fr) 1994-09-28
US5665535A (en) 1997-09-09
CA2098819A1 (fr) 1992-06-21

Similar Documents

Publication Publication Date Title
CA2098819C (fr) Sequences d'adn derivees du genome du papillomavirus hpv39, leur application au diagnostic in vitro et a la production de composition immunogene
EP0462187B1 (fr) Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
Schiller et al. Current understanding of the mechanism of HPV infection
JP4505452B2 (ja) 酵母におけるｈｐｖ３１ｌ１の最適化発現
Mossadegh et al. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells
EP0342128B1 (fr) Sondes à papillomavirus (HPV49, HPV50, HPV54, HPV55), produits génétiquement et immunologiquement liés à ce papillomavirus et procédé de diagnostic in vitro d'infection à papillomavirus et de production d'anticorps contre ces papillomavirus
CA1279276C (fr) Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro a la prevention et/ou la lutte contre des infections a papillomavirus
Iftner et al. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium
CA2112096C (fr) Sequences d'adn du papillomavirus hpv42 - application au diagnostic
AU2005268646B2 (en) HPV vaccine comprising peptides from host cell proteins
Nicholls et al. Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions
US6395512B1 (en) DNA coding for a peptide of a papilloma virus main capside protein and use thereof
US6610473B1 (en) Peptides for inhibiting HPV E6-proteins
Egelkrout et al. 27 The Biology of Genital Human Papillomaviruses
WO1991018118A1 (fr) Sonde a papillomavirus (hpv66), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus
Zheng Human papillomaviruses
Green et al. Development of a topical protein therapeutic for human papillomavirus and associated cancers
WO1991009866A1 (fr) Sonde a papillomavirus (hpv63), notamment pour le diagnostic in vitro d'infections a papillomavirus, pouvant s'accompagner de neoplasies genitales, et produits genetiquement et immunologiquement lies a ce papillomavirus
Moody et al. The life cycle of human papillomaviruses
Sankovski Studies on papillomavirus transcription and regulatory protein E2
Cruz Diversity in Papillomavirus Host Interactions During Attachment and Entry
Ryding Human Papillomavirus vaccination: Immunological and epidemiological studies
FR2758725A1 (fr) Composition comprenant une proteine e2 de papillomavirus ou une sequence de nucleotides codant pour une proteine e2 de papillomavirus
Crawford Vaccines against human papillomaviruses and associated tumors
HPV34 et al. Group B Sequences

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry